ADVENZYMES

Advanced Enzyme Technologies Share Price

₹361.20 -13.2 (-3.53%)

21 Dec, 2024 18:32

SIP TrendupStart SIP in ADVENZYMES

Start SIP

Performance

  • Low
  • ₹361
  • High
  • ₹376
  • 52 Week Low
  • ₹334
  • 52 Week High
  • ₹571
  • Open Price₹374
  • Previous Close₹374
  • Volume222,525

Investment Returns

  • Over 1 Month -4.39%
  • Over 3 Month -32.87%
  • Over 6 Month -7.65%
  • Over 1 Year -0.67%
SIP Lightning

Smart Investing Starts Here Start SIP with Advanced Enzyme Technologies for Steady Growth!

Invest Now

Advanced Enzyme Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.5
  • PEG Ratio
  • 3
  • Market Cap Cr
  • 4,041
  • P/B Ratio
  • 2.9
  • Average True Range
  • 15.7
  • EPS
  • 13.16
  • Dividend Yield
  • 1.4
  • MACD Signal
  • -13.86
  • RSI
  • 35.2
  • MFI
  • 60.86

Advanced Enzyme Technologies Financials

Advanced Enzyme Technologies Technicals

EMA & SMA

Current Price
₹361.20
-13.2 (-3.53%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹383.96
  • 50 Day
  • ₹409.52
  • 100 Day
  • ₹420.93
  • 200 Day
  • ₹409.82

Resistance and Support

366.07 Pivot Speed
  • R3 386.13
  • R2 381.07
  • R1 371.13
  • S1 356.13
  • S2 351.07
  • S3 341.13

What's your outlook on Advanced Enzyme Technologies?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Advanced Enzyme Technologies Ltd. is a leading global manufacturer of enzymes and probiotics, catering to various industries including pharmaceuticals, food, animal nutrition, and textiles. It offers sustainable, high-performance solutions that enhance efficiency and reduce environmental impact.

Advanced Enzyme Techs. has an operating revenue of Rs. 619.37 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 30% is great, ROE of 10% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 48 which is a POOR score indicating inconsistency in earnings, a RS Rating of 16 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 94 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Advanced Enzyme Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-09 Quarterly Results
2024-08-10 Quarterly Results
2024-05-11 Audited Results & Dividend
2024-02-10 Quarterly Results
2023-11-07 Quarterly Results
Date Purpose Remarks
2024-07-18 FINAL Rs.1.10 per share(55%)Final Dividend
2024-05-18 INTERIM Rs.4.00 per share(200%)Interim Dividend
2023-08-05 FINAL Rs.1.00 per share(50%)Final Dividend
2023-05-20 INTERIM Rs.4.00 per share(200%)Interim Dividend
2022-08-12 FINAL Rs.1.00 per share(50%)Final Dividend

Advanced Enzyme Technologies F&O

Advanced Enzyme Technologies Shareholding Pattern

42.95%
5.57%
12.63%
16.05%
22.8%

About Advanced Enzyme Technologies

  • NSE Symbol
  • ADVENZYMES
  • BSE Symbol
  • 540025
  • ISIN
  • INE837H01020

Similar Stocks to Advanced Enzyme Technologies

Advanced Enzyme Technologies FAQs

Advanced Enzyme Technologies share price is ₹361 As on 21 December, 2024 | 18:18

The Market Cap of Advanced Enzyme Technologies is ₹4041.1 Cr As on 21 December, 2024 | 18:18

The P/E ratio of Advanced Enzyme Technologies is 29.5 As on 21 December, 2024 | 18:18

The PB ratio of Advanced Enzyme Technologies is 2.9 As on 21 December, 2024 | 18:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23